UK launches vaccine development hubs in $43 million project 06-Nov-2023 By Jonathan Smith The UK has unveiled £34.5 million ($42.8 million) in funding for four hubs dedicated to the development of vaccines for diseases with epidemic potential in low- and middle-income countries (LMICs).
New malaria vaccine licensed for use in Ghana 13-Apr-2023 By Rachel Arthur The R21/Matrix-M malaria vaccine, developed by the University of Oxford, has received its first regulatory clearance.